R T Dorr
- Dermatology top 1%
- Chemotherapy-related skin toxicity 5
- Biochemistry top 5%
- Oncology top 5%
- Cancer Treatment and Pharmacology 6
-
- Cancer therapeutics and mechanisms 10
-
- Bioactive Compounds and Antitumor Agents 6
-
- Synthesis and Biological Evaluation 5
- Click Chemistry and Applications 5
-
- Acute Lymphoblastic Leukemia research 5
-
- Pharmaceutical studies and practices 4
- Co-authors
- David S. AlbertsWilliam S. DaltonYan CaiFazal Imam ShahiJames A. CrowellC S YangH.‐H. Sherry ChowIman A. Hakim
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
R T Dorr
58 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 112
- Dermatology 326
- Applied Microbiology and Biotechnology 68
- Biochemistry 177
- Oncology 727
- Pathology and Forensic Medicine 328
Countries citing papers authored by R T Dorr
This map shows the geographic impact of R T Dorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R T Dorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R T Dorr more than expected).
Fields of papers citing papers by R T Dorr
This network shows the impact of papers produced by R T Dorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R T Dorr. The network helps show where R T Dorr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R T Dorr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 5 | |
| 2 | 2001 | 37 | |
| 3 | Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. | 2001 | 338 |
| 4 | 1999 | 90 | |
| 5 | 1996 | 32 | |
| 6 | 1996 | 24 | |
| 7 | 1994 | 10 | |
| 8 | Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells. | 1993 | 23 |
| 9 | 1992 | 30 | |
| 10 | 1991 | 4 | |
| 11 | 1991 | 3 | |
| 12 | 1990 | 46 | |
| 13 | 1990 | 99 | |
| 14 | 1989 | 4 | |
| 15 | 1988 | 12 | |
| 16 | 1987 | 2 | |
| 17 | 1987 | 49 | |
| 18 | Characterization of a mitomycin C (MMC) resistant L-1210 cell line | 1985 | 1 |
| 19 | Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. | 1985 | 29 |
| 20 | Vinca alkaloid ulceration: experimental mouse model and effects of local antidotes. Abstr. | 1982 | 2 |
About R T Dorr
R T Dorr is a scholar working on Toxicology, Dermatology and Occupational Therapy, having authored 59 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Bioactive Compounds and Antitumor Agents (6 papers), Cancer Treatment and Pharmacology (6 papers), Synthesis and Biological Evaluation (5 papers), Chemotherapy-related skin toxicity (5 papers), Click Chemistry and Applications (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Dermatology (326 citations), Applied Microbiology and Biotechnology (68 citations) and Biochemistry (177 citations). R T Dorr has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include David S. Alberts, William S. Dalton, David S. Alberts, Yan Cai, Fazal Imam Shahi, James A. Crowell, C S Yang, H.‐H. Sherry Chow, Iman A. Hakim and Yukihiko Hara.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.